文献速递创面修复

富血小板血浆敷料治疗慢性难愈性溃疡:15项随机对照试验的Meta分析

The Efficacy of Platelet-Rich Plasma Dressing for Chronic Nonhealing Ulcers: A Meta-Analysis of 15 Randomized Controlled Trials.
PubMed 文献 · Plast Reconstr Surg · 2019-01-01

该Meta分析纳入2000至2018年15项随机对照试验共630例成年患者,比较富血小板血浆与标准创面护理对慢性难愈性溃疡的疗效。结果显示富血小板血浆组溃疡愈合数量显著高于对照组(RR=1.26,95%CI 1.11-1.42,P=0.0003),第4周随访时愈合数量亦显著更多(RR=3.50,95%CI 1.80-6.81,P=0.0002)。结论认为富血小板血浆是安全有价值的治疗敷料。

要点

  • 富血小板血浆组溃疡愈合数量显著高于标准创面护理组(RR=1.26,P=0.0003)。
  • 第4周随访时富血小板血浆组愈合数量显著更多(RR=3.50,P=0.0002)。
  • 富血小板血浆制备简单、效果显著,可作为慢性难愈性溃疡的安全治疗敷料。

核心结论

  • 富血小板血浆是慢性难愈性溃疡有价值且安全的治疗敷料,制备简单且效果显著。
  • 仍需进一步高质量前瞻性研究验证上述结果。

研究设计与样本

  • Meta分析,检索PubMed、EMBASE、EBSCO(CINAHL)和Cochrane数据库至2018年11月。
  • 纳入15项随机对照试验,共630例成年患者,比较富血小板血浆与标准创面护理。
  • 二分类结局计算风险比(RR),连续结局用均数差表示,并按慢性溃疡类型进行亚组分析。

主要发现

  • 富血小板血浆组溃疡愈合数量高于对照组,差异有统计学意义(RR=1.26,95%CI 1.11-1.42,P=0.0003)。
  • 第4周随访时富血小板血浆组愈合数量显著多于对照组(RR=3.50,95%CI 1.80-6.81,P=0.0002)。

临床怎么用

  • 可考虑将富血小板血浆敷料用于慢性难愈性溃疡以促进愈合。
  • 需结合溃疡类型评估获益,并关注第4周的早期愈合表现。

局限性

  • 原文未报告具体局限性内容。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Several randomized controlled trials comparing platelet-rich plasma to standard wound care for chronic wounds have been published. Previous articles have revealed that the role of platelet-rich plasma in promoting chronic wound healing is uncertain. This quantitative meta-analysis was conducted to evaluate whether superior outcomes can be obtained by using platelet-rich plasma in nonhealing ulcers compared with traditional wound care. METHODS: The PubMed, EMBASE, EBSCO (Cumulative Index to Nursing and Allied Health Literature), and Cochrane databases were searched through November of 2018 for randomized controlled trials comparing platelet-rich plasma to standard wound care for chronic wounds. For binary outcome measures, we calculated the risk ratio. The continuous outcomes were expressed as the mean differences. Subgroup analyses were also performed according to the type of chronic ulcer. RESULTS: Overall, 630 adult patients in 15 randomized controlled trials from 2000 to 2018 were included. The number of ulcers healed in the platelet-rich plasma group was higher than in the control group, and the difference was statistically significant (risk ratio, 1.26; 95 percent CI, 1.11 to 1.42; p = 0.0003). During the fourth week of follow-up, the number of ulcers healed in the platelet-rich plasma group was significantly greater than in the control group (risk ratio, 3.50; 95 percent CI, 1.80 to 6.81; p = 0.0002). CONCLUSIONS: Platelet-rich plasma is a valuable and safe treatment dressing for chronic nonhealing ulcers; it is simple to prepare and has remarkable effects. Further high-quality prospective studies are necessary to validate these results. CLINICAL QUESTION/LEVEL OF EVIDENCE: Therapeutic, II.

来源:Plast Reconstr Surg,查看原文。版权归原作者所有。

引用

  1. Xia Y, Zhao J, Xie J, et al. The Efficacy of Platelet-Rich Plasma Dressing for Chronic Nonhealing Ulcers: A Meta-Analysis of 15 Randomized Controlled Trials. Plast Reconstr Surg. 2019. PMID: 31764670. doi:10.1097/PRS.0000000000006281

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。